Objective: To observe the efficacy and safety of Guihuang Formula(GHF) in treating patients with type Ⅲ prostatitis and Chinese medicine syndrome of dampness-heat and blood stasis. Methods: Sixty-six type Ⅲ prostati...Objective: To observe the efficacy and safety of Guihuang Formula(GHF) in treating patients with type Ⅲ prostatitis and Chinese medicine syndrome of dampness-heat and blood stasis. Methods: Sixty-six type Ⅲ prostatitis patients with dampness-heat and blood stasis syndrome were randomly divided into the treatment group(GHF) and the control group(tamsulosin) using a random number table, with 33 cases each group. The treatment group received GHF twice a day, and the control group received tamsulosin 0.2 mg once daily before bedtime. Patients in both groups received treatment for 6 weeks and was followed up for 2 weeks. The outcomes included the National Institute of Health Chronic Prostatitis Symptom Index(NIH-CPSI) score, Chinese Medicine Symptoms Score(CMSS), expressed prostatic secretions(EPS) and adverse events(AEs). Results: After treatment, the NIH-CPSI total score and domain scores of pain discomfort, urination and quality of life decreased significantly from the baseline in both groups(P<0.05). The CMSS score decreased in both groups(P<0.05). The white blood cell(WBC) count decreased and lecithin body count increased in both groups(P<0.05). GHF showed a more obvious advantage in reducing the pain discomfort and quality of life domain scores of NIH-CPSI, reducing the CMSS score, increasing the improvement rate of the WBC and lecithin body counts, compared with the control group(P<0.05). There were no significant differences in decreasing urination domain score of NIH-CPSI between two groups(P>0.05). In addition, no serious AEs were observed. Conclusion: GHF is effective in treating type Ⅲ prostatitis patients with dampness-heat and blood stasis syndrome without serious AEs.(Registration No. ChiCTR1900026966)展开更多
After 160 cases of chronic type Ⅲ prostatitis were divided into the treatment group （n= 80） and control group （n = 80）, in the treatment group, first Zhibian （BL 54） was punctured toward Shuidao （ST 28） and t...After 160 cases of chronic type Ⅲ prostatitis were divided into the treatment group （n= 80） and control group （n = 80）, in the treatment group, first Zhibian （BL 54） was punctured toward Shuidao （ST 28） and then Qihai （CV 6）, Guanyuan （CV 4）, Shuidao （ST 28） Baihui （GV 20）, Fengchi （GB 20）, Sishencong （Ex-HN 1）, Sanyinjiao （SP 6） and Taichong （LR 3） were punctured, and at the same time, digital computerized microwave apparatus was inserted into the anus for microwave treatment. Afterward, moritatherapy was applied for psychological consultation for the patients. In the control group, compound sinomin and Phenoxybenzamine Hydrochloride Tablets were used orally. The results showed that the therapeutic effects were respectively 92.5% and 68.8% in two groups, with statistic significance （P〈 0.01）.展开更多
Objective:To evaluate the therapeutic effect of acupuncture combined with acupoint injection on chronic nonbacterial prostatitis(CNP).Methods:A total of 72 CNP patients admitted between March 2022 and October 2023 wer...Objective:To evaluate the therapeutic effect of acupuncture combined with acupoint injection on chronic nonbacterial prostatitis(CNP).Methods:A total of 72 CNP patients admitted between March 2022 and October 2023 were selected.The patients were randomly divided into two groups using a random number table.The combined treatment group(36 cases)received acupuncture combined with acupoint injection therapy,while the control group(36 cases)received conventional Western medicine treatment.The overall efficacy rate,symptom severity,prostatic fluid indicators,incidence of adverse reactions,and recurrence rates were compared.Results:The overall efficacy rate of the combined treatment group was higher than that of the control group(P<0.05).After 10 days of treatment,the symptom severity score of the combined treatment group was higher than that of the control group,and the prostatic fluid indicators were lower than those of the control group(P<0.05).The incidence of adverse reactions in the combined treatment group was lower than in the control group(P<0.05).During the follow-up period of 1-6 months,the recurrence rate in the combined treatment group was lower than that in the control group(P<0.05).Conclusion:Acupuncture combined with acupoint injection can alleviate CNP disease symptoms,improve prostate function,and prevent post-treatment adverse reactions.It also has a lower recurrence risk and demonstrates excellent efficacy.展开更多
Prostate cancer(PCa)is one of the most common malignant tumors in the male genitourinary system,ranking second in incidence worldwide.Traditional Chinese medicine(TCM),as an important component of complementary and al...Prostate cancer(PCa)is one of the most common malignant tumors in the male genitourinary system,ranking second in incidence worldwide.Traditional Chinese medicine(TCM),as an important component of complementary and alternative medicine,shows unique advantages in cancer treatment.Chinese herbal medicine is usually composed of multiple ingredients and involves multiple signaling pathways,which showed function of inducing apoptosis of cancer cells,arresting the cell cycle,inhibiting invasion and metastasis,reducing drug resistance,and regulating immune function.Physical therapy is also an important treatment of TCM.Currently,Physical therapy such as acupuncture or Tai Chi and Qigong are gaining increased recognition in the management of PCa,particularly in addressing issues like urinary incontinence and bone metastasis-related pain.This article reviews the TCM treatment and therapy of PCa,in order to provide new research avenues and treatment options for the treatment of PCa with TCM and improve the quality of life of patients.展开更多
Objective To observe the clinical effect of Yishen Tongluo Recipe (YSTLR) on type Ⅲ prostatitis of Shen deficiency and collaterals obstruction.Methods Totally120 type Ⅲ prostatitis patients with Shen deficiency and ...Objective To observe the clinical effect of Yishen Tongluo Recipe (YSTLR) on type Ⅲ prostatitis of Shen deficiency and collaterals obstruction.Methods Totally120 type Ⅲ prostatitis patients with Shen deficiency and collaterals obstruction were randomly assigned to treatment group and control group,60 in each group.展开更多
Objective To compare the difference in the clinical efficacy on typeⅢprostatitis between the combined therapy of acupuncture with isolated-ginger moxibustion and tamsulosin.Methods One hundred and ten patients
目的观察电生理适宜技术治疗ⅢB型慢性前列腺炎(chronic prostatitis,CP)的临床疗效,为电生理适宜技术在男科疾病诊治中的应用提供临床数据。方法通过自身配对前后对照方法研究2021年12月至2022年11月在柳州市柳铁中心医院男科行电生理...目的观察电生理适宜技术治疗ⅢB型慢性前列腺炎(chronic prostatitis,CP)的临床疗效,为电生理适宜技术在男科疾病诊治中的应用提供临床数据。方法通过自身配对前后对照方法研究2021年12月至2022年11月在柳州市柳铁中心医院男科行电生理适宜技术治疗的ⅢB型慢性前列腺炎患者,根据纳入和排除标准共收集31例。所有研究对象治疗前后分别行可视化精准电生理诊断(visual and accurate electrophysiological diagnosis,VAED)及填写慢性前列腺炎症状指数(NIH-CPSI)评分、慢性前列腺炎症状严重程度(CP/CPSI)评分表、国际前列腺症状评分(IPSS)及焦虑症筛查量表(GAD-7),观察临床疗效。结果治疗后NIH-CPSI评分、CP/CPSI评分、IPSS评分、GAD-7评分均低于治疗前,差异有统计学意义(均P<0.05)。VAED扫描后热像图(TMT)显示腹股沟最低温度、腹股沟平均温度均低于治疗前,差异有统计学意义(均P<0.05)。结论电生理适宜技术治疗ⅢB型慢性前列腺炎安全、疗效肯定,可显著改善患者疼痛、焦虑症状,提高生活质量。展开更多
目的:基于网络药理学和分子对接方法,确定复方黄柏液治疗的Ⅲ度烧伤肉芽组织愈合的有效活性成分、关键靶点和潜在的药理学机制,并进行肉芽组织成纤维细胞的初步验证。方法:从公共数据库中药系统药理学分析平台(TCMSP)检索复方黄柏液组...目的:基于网络药理学和分子对接方法,确定复方黄柏液治疗的Ⅲ度烧伤肉芽组织愈合的有效活性成分、关键靶点和潜在的药理学机制,并进行肉芽组织成纤维细胞的初步验证。方法:从公共数据库中药系统药理学分析平台(TCMSP)检索复方黄柏液组成成分连翘、黄柏、金银花的有效成分和靶点;GeneCards、OMIM数据库检索“Ⅲ度烧伤”疾病相关靶点。通过生物信息学分析,包括蛋白质-蛋白质相互作用(Protein-proteininteraction,PPI)以及基因本体(Gene ontology,GO)和京都基因和基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)分析,获得了关键的有效成分、核心靶点和相关信号通路;DiscoveryStudio分子对接分析有效成分化合物与靶蛋白的结合。0.5%的DMSO溶液处理的成纤维细胞记为对照组;槲皮素(40μmol/ml)处理的成纤维细胞记为槲皮素组。采用CCK8法、Transwell实验检测细胞增殖、迁移侵袭;WB试验检测细胞p-PI3K、p-Akt蛋白。结果:共筛选出74个有效成分,331个作用靶点,AKT1为潜在的治疗靶点,木犀草素、山柰酚、槲皮素、汉黄芩素、丹皮酚为潜在的候选药物。PI3K-AKT信号通路可能在复方黄柏液治疗Ⅲ度烧伤中发挥关键作用;分子对接表明槲皮素与AKT1结合最好。与对照组相比,槲皮素组成纤维细胞增殖、迁移侵袭均显著降低,p-PI3K、p-Akt蛋白表达也显著降低(P<0.05)。结论:复方黄柏液促进Ⅲ度烧伤患者肉芽组织形成的生物活性成分为槲皮素,潜在通路为PI3K-AKT信号通路,为复方黄柏液治疗Ⅲ度烧伤的研究提供了思路。展开更多
基金Supported by the National Natural Science Foundation of China (No.82104880)Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences (No.CI2021A02208)the Nursery Project of Xiyuan Hospital of China Academy of Chinese Medical Sciences (No.2019XYMP-23)。
文摘Objective: To observe the efficacy and safety of Guihuang Formula(GHF) in treating patients with type Ⅲ prostatitis and Chinese medicine syndrome of dampness-heat and blood stasis. Methods: Sixty-six type Ⅲ prostatitis patients with dampness-heat and blood stasis syndrome were randomly divided into the treatment group(GHF) and the control group(tamsulosin) using a random number table, with 33 cases each group. The treatment group received GHF twice a day, and the control group received tamsulosin 0.2 mg once daily before bedtime. Patients in both groups received treatment for 6 weeks and was followed up for 2 weeks. The outcomes included the National Institute of Health Chronic Prostatitis Symptom Index(NIH-CPSI) score, Chinese Medicine Symptoms Score(CMSS), expressed prostatic secretions(EPS) and adverse events(AEs). Results: After treatment, the NIH-CPSI total score and domain scores of pain discomfort, urination and quality of life decreased significantly from the baseline in both groups(P<0.05). The CMSS score decreased in both groups(P<0.05). The white blood cell(WBC) count decreased and lecithin body count increased in both groups(P<0.05). GHF showed a more obvious advantage in reducing the pain discomfort and quality of life domain scores of NIH-CPSI, reducing the CMSS score, increasing the improvement rate of the WBC and lecithin body counts, compared with the control group(P<0.05). There were no significant differences in decreasing urination domain score of NIH-CPSI between two groups(P>0.05). In addition, no serious AEs were observed. Conclusion: GHF is effective in treating type Ⅲ prostatitis patients with dampness-heat and blood stasis syndrome without serious AEs.(Registration No. ChiCTR1900026966)
文摘After 160 cases of chronic type Ⅲ prostatitis were divided into the treatment group （n= 80） and control group （n = 80）, in the treatment group, first Zhibian （BL 54） was punctured toward Shuidao （ST 28） and then Qihai （CV 6）, Guanyuan （CV 4）, Shuidao （ST 28） Baihui （GV 20）, Fengchi （GB 20）, Sishencong （Ex-HN 1）, Sanyinjiao （SP 6） and Taichong （LR 3） were punctured, and at the same time, digital computerized microwave apparatus was inserted into the anus for microwave treatment. Afterward, moritatherapy was applied for psychological consultation for the patients. In the control group, compound sinomin and Phenoxybenzamine Hydrochloride Tablets were used orally. The results showed that the therapeutic effects were respectively 92.5% and 68.8% in two groups, with statistic significance （P〈 0.01）.
基金supported by grants from the scientific research project of Jilin Provincial Department of Education(Project No.JJKH20231001KJ)the key research and development project on Baicheng Glycyrrhiza of Baicheng Medical College(Project No.BCGC202420).
文摘Objective:To evaluate the therapeutic effect of acupuncture combined with acupoint injection on chronic nonbacterial prostatitis(CNP).Methods:A total of 72 CNP patients admitted between March 2022 and October 2023 were selected.The patients were randomly divided into two groups using a random number table.The combined treatment group(36 cases)received acupuncture combined with acupoint injection therapy,while the control group(36 cases)received conventional Western medicine treatment.The overall efficacy rate,symptom severity,prostatic fluid indicators,incidence of adverse reactions,and recurrence rates were compared.Results:The overall efficacy rate of the combined treatment group was higher than that of the control group(P<0.05).After 10 days of treatment,the symptom severity score of the combined treatment group was higher than that of the control group,and the prostatic fluid indicators were lower than those of the control group(P<0.05).The incidence of adverse reactions in the combined treatment group was lower than in the control group(P<0.05).During the follow-up period of 1-6 months,the recurrence rate in the combined treatment group was lower than that in the control group(P<0.05).Conclusion:Acupuncture combined with acupoint injection can alleviate CNP disease symptoms,improve prostate function,and prevent post-treatment adverse reactions.It also has a lower recurrence risk and demonstrates excellent efficacy.
基金supported by China Postdoctoral Science Foundation(2022M722674)Peixian Science and Technology Plan Project(P202410)Xuzhou Medical Reserve Talents Project(XWRCHT20220009).
文摘Prostate cancer(PCa)is one of the most common malignant tumors in the male genitourinary system,ranking second in incidence worldwide.Traditional Chinese medicine(TCM),as an important component of complementary and alternative medicine,shows unique advantages in cancer treatment.Chinese herbal medicine is usually composed of multiple ingredients and involves multiple signaling pathways,which showed function of inducing apoptosis of cancer cells,arresting the cell cycle,inhibiting invasion and metastasis,reducing drug resistance,and regulating immune function.Physical therapy is also an important treatment of TCM.Currently,Physical therapy such as acupuncture or Tai Chi and Qigong are gaining increased recognition in the management of PCa,particularly in addressing issues like urinary incontinence and bone metastasis-related pain.This article reviews the TCM treatment and therapy of PCa,in order to provide new research avenues and treatment options for the treatment of PCa with TCM and improve the quality of life of patients.
文摘Objective To observe the clinical effect of Yishen Tongluo Recipe (YSTLR) on type Ⅲ prostatitis of Shen deficiency and collaterals obstruction.Methods Totally120 type Ⅲ prostatitis patients with Shen deficiency and collaterals obstruction were randomly assigned to treatment group and control group,60 in each group.
文摘Objective To compare the difference in the clinical efficacy on typeⅢprostatitis between the combined therapy of acupuncture with isolated-ginger moxibustion and tamsulosin.Methods One hundred and ten patients
文摘目的观察电生理适宜技术治疗ⅢB型慢性前列腺炎(chronic prostatitis,CP)的临床疗效,为电生理适宜技术在男科疾病诊治中的应用提供临床数据。方法通过自身配对前后对照方法研究2021年12月至2022年11月在柳州市柳铁中心医院男科行电生理适宜技术治疗的ⅢB型慢性前列腺炎患者,根据纳入和排除标准共收集31例。所有研究对象治疗前后分别行可视化精准电生理诊断(visual and accurate electrophysiological diagnosis,VAED)及填写慢性前列腺炎症状指数(NIH-CPSI)评分、慢性前列腺炎症状严重程度(CP/CPSI)评分表、国际前列腺症状评分(IPSS)及焦虑症筛查量表(GAD-7),观察临床疗效。结果治疗后NIH-CPSI评分、CP/CPSI评分、IPSS评分、GAD-7评分均低于治疗前,差异有统计学意义(均P<0.05)。VAED扫描后热像图(TMT)显示腹股沟最低温度、腹股沟平均温度均低于治疗前,差异有统计学意义(均P<0.05)。结论电生理适宜技术治疗ⅢB型慢性前列腺炎安全、疗效肯定,可显著改善患者疼痛、焦虑症状,提高生活质量。
文摘目的:基于网络药理学和分子对接方法,确定复方黄柏液治疗的Ⅲ度烧伤肉芽组织愈合的有效活性成分、关键靶点和潜在的药理学机制,并进行肉芽组织成纤维细胞的初步验证。方法:从公共数据库中药系统药理学分析平台(TCMSP)检索复方黄柏液组成成分连翘、黄柏、金银花的有效成分和靶点;GeneCards、OMIM数据库检索“Ⅲ度烧伤”疾病相关靶点。通过生物信息学分析,包括蛋白质-蛋白质相互作用(Protein-proteininteraction,PPI)以及基因本体(Gene ontology,GO)和京都基因和基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)分析,获得了关键的有效成分、核心靶点和相关信号通路;DiscoveryStudio分子对接分析有效成分化合物与靶蛋白的结合。0.5%的DMSO溶液处理的成纤维细胞记为对照组;槲皮素(40μmol/ml)处理的成纤维细胞记为槲皮素组。采用CCK8法、Transwell实验检测细胞增殖、迁移侵袭;WB试验检测细胞p-PI3K、p-Akt蛋白。结果:共筛选出74个有效成分,331个作用靶点,AKT1为潜在的治疗靶点,木犀草素、山柰酚、槲皮素、汉黄芩素、丹皮酚为潜在的候选药物。PI3K-AKT信号通路可能在复方黄柏液治疗Ⅲ度烧伤中发挥关键作用;分子对接表明槲皮素与AKT1结合最好。与对照组相比,槲皮素组成纤维细胞增殖、迁移侵袭均显著降低,p-PI3K、p-Akt蛋白表达也显著降低(P<0.05)。结论:复方黄柏液促进Ⅲ度烧伤患者肉芽组织形成的生物活性成分为槲皮素,潜在通路为PI3K-AKT信号通路,为复方黄柏液治疗Ⅲ度烧伤的研究提供了思路。
